Developing a model for decision-making around antibiotic prescribing for patients with COVID-19 pneumonia in acute NHS hospitals during the first wave of the COVID-19 pandemic: qualitative results from the Procalcitonin Evaluation of Antibiotic use in COVID-19 Hospitalised patients (PEACH Study).
Josie HenleyLucy Brookes-HowellJoanne EudenPhilip PallmannMartin J LlewelynPhilip HowardNeil PowellPaul DarkTamás SzakmanyThomas P HellyerMahableswhar AlburRyan HamiltonGraham PrestwichMargaret OgdenWakunyambo MabosheJonathan A T SandoeEmma Thomas-JonesEnitan D Carrolnull nullnull nullPublished in: BMJ open (2023)
ISRCTN66682918.
Keyphrases
- end stage renal disease
- decision making
- coronavirus disease
- ejection fraction
- sars cov
- primary care
- newly diagnosed
- chronic kidney disease
- healthcare
- liver failure
- prognostic factors
- peritoneal dialysis
- emergency department
- intensive care unit
- adverse drug
- aortic dissection
- hepatitis b virus
- respiratory syndrome coronavirus